C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 14/605 (2006.01) A61K 38/26 (2006.01) G01N 33/74 (2006.01)
Patent
CA 2260291
Antagonists of glucagon-like peptide 2 have been identified. Their effects on the growth of gastrointestinal tissue are described. Its formulation as a pharmaceutical, and its therapeutic and related uses in treating bowel tissue, are described. Also described are methods of identifying antagonists of glucagon-like peptide 2.
Divulgation d'antagonistes du peptide-2 de type glucagon. Divulgation de leurs effets sur la croissance du tissu gastro-intestinal. Divulgation de leur formulation comme produit pharmaceutique, ainsi que de leurs utilisations thérapeutiques et connexes pour le traitement du tissu intestinal. Divulgation aussi de méthodes pour identifier des antagonistes du peptide-2 semblables au glucagon.
Crivici Anna E.
Drucker Daniel J.
Sumner-Smith Martin
1149336 Ontario Inc.
Allelix Biopharmaceuticals Inc.
Nps Pharmaceuticals Inc.
Osler Hoskin & Harcourt Llp
LandOfFree
Antagonists of intestinotrophic glp-2 peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antagonists of intestinotrophic glp-2 peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antagonists of intestinotrophic glp-2 peptides will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1669297